Galectin-1 as an oncotarget in gliomas and melanomas

Oncotarget

Volumn 2, Issue 12, 2011, Pages 892-893

  Lefranc, Florence ^a   Mathieu, Véronique ^a   Kiss, Robert ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 1;

EDITORIAL; GLIOMA; HUMAN; IMMUNOLOGY; MELANOMA; METABOLISM; TH1 CELL; TH17 CELL; TUMOR ESCAPE;

GALECTIN 1; GLIOMA; HUMANS; MELANOMA; TH1 CELLS; TH17 CELLS; TUMOR ESCAPE;

EID: 84862998022     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.408     Document Type: Note

References (9)

1. Perillo NL, Pace KE, Seilhamer JJ et al. Nature 1995 ; 378(6558) :736-739.
2. Rubinstein N, Alvarez M, Zwimer NW et al. Cancer Cell. 2004; 5(3):241-251.
3. Liu FT, Rabinovich GA. Nat Rev Cancer. 2005; 5(1):29- 41.
4. Lefranc F, Mathieu V, Kiss R. World J Biol Chem. 2011; 2(9):193-201.
5. Camby I, Le Mercier M et al. Glycobiology. 2006; 16(11):137R-157R.
6. Thijssen VL, Postel R, Brandwijk RJ et al. Proc Natl Acad Sci USA. 2006; 103(43):15975-15980.
7. Ilarregui JM, Rabinovich GA. Neuroimmunomodulation. 2010; 17(3):157-160.
8. Le Mercier M, Mathieu V, Haibe-Kains B et al. J Neuropathol Exp Neurol. 2008; 67(5):456-469.
9. Thijssen VL, Barkan B, Shoji H et al. Cancer Res. 2010; 70(15):6216-6224